Outcomes Reporting in Specialty Highlights SPT Week in Review

Top news of the week from Specialty Pharmacy Times.

5. Sanofi, Regeneron to Reduce Costs for PCSK9 Inhibitor for Value-Based Contracts

Payers may achieve an additional discount for alirocumab (Praluent) if they agree to value-based contracts. Read more.


Fish Consumption Linked to Lower Multiple Sclerosis Risk

Intake of fish high in omega-3 fatty acids could help reduce the risk of developing multiple sclerosis or clinically isolated syndrome. Read more.


Drug Costs May Not Solely Drive Increasing US Health Care Spending

Administrative costs and surgical procedures may contribute significantly to overspending on health care in the United States. Read more.


Top 3 Most Common Cognitive Effects of Multiple Sclerosis

Patients with multiple sclerosis may be at a higher risk of developing mental health conditions. Read more.


Outcomes Reporting: A Specialty Pharmacy Core Competency

Collecting data that show the most efficient and effective ways to clinically manage patients is becoming more important than ever in specialty pharmacy. Read more.